Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZient. The standardized and automated platform...
Visible Alpha, a financial technology company that improves the investment research process by capturing value from sell-side analyst models, research reports and corporate access...
Parse Biosciences, the premier provider of easy-to-use, scalable single-cell sequencing solutions, announced an agreement with INTEGRA Biosciences to combine Assist Plus with built-in Parse...
Veracyte, Inc., a leading cancer diagnostics company, announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities...
